![](https://monteverdelaw.com/wp-content/uploads/case-logo/biodelivery-sciences-international-inc.png)
BioDelivery Sciences International, Inc. (BDSI), relating to its acquisition by Collegium Pharmaceutical, Inc. Under the terms of the agreement, BDSI shareholders will receive $5.60 in cash per share they own.
BioDelivery Sciences International, Inc. (BDSI), relating to its acquisition by Collegium Pharmaceutical, Inc. Under the terms of the agreement, BDSI shareholders will receive $5.60 in cash per share they own.